Evidence map›Paper›PMID 23392248›Full record

ReviewRNA biology2013

The interplay of Hfq, poly(A) polymerase I and exoribonucleases at the 3' ends of RNAs resulting from Rho-independent termination: A tentative model.

Philippe Régnier, Eliane Hajnsdorf

Abstract readReview
In one paragraph

Review in RNA biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. RNA polyadenylation and its consequences in prokaryotes.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Review
  7. Article
  8. RNA-binding proteins in bacteria.Nature reviews. Microbiology · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Special focus Hfq.RNA biology · 2013
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Philippe RégnierUniversity Paris Diderot, Sorbonne Paris Cité, Institut de Biologie Physico-Chimique, Paris, France. regnier@ibpc.fr
Eliane Hajnsdorf

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Discovered in eukaryotes as a modification essential for mRNA function, polyadenylation was then identified as a means used by all cells to destabilize RNA. In Escherichia coli, most accessible 3' RNA extremities are believed to be potential targets of poly(A) polymerase I. However, some RNAs might be preferentially adenylated. After a short statement of the current knowledge of poly(A) metabolism, we discuss how Hfq could affect recognition and polyadenylation of RNA terminated by Rho-independent terminators. Comparison of RNA terminus leads to the proposal that RNAs harboring 3' terminal features required for Hfq binding are not polyadenylated, whereas those lacking these structural elements can gain the oligo(A) tails that initiate exonucleolytic degradation. We also speculate that Hfq stimulates the synthesis of longer tails that could be used as Hfq-binding sites involved in non-characterized functions of Hfq-dependent sRNAs.

Indexed as

PolyadenylationRNA StabilityBacterial ProteinsBinding SitesEscherichia coliEscherichia coli ProteinsExoribonucleasesGene Expression Regulation, BacterialHost Factor 1 ProteinPoly ARepressor ProteinsRho FactorRNA-Binding ProteinsRNA, MessengerRNA, Small UntranslatedSequence AlignmentBacterial ProteinsEscherichia coli ProteinsExoribonucleasesHost Factor 1 ProteinPapI protein, E coliPoly ARepressor ProteinsRho FactorRNA-Binding ProteinsRNA, MessengerRNA, Small Untranslatedexoribonucleasesoligo(A) tailspolyadenylationpoly(A) polymeraseprotein HfqRho-independent terminatorsRNA degradation

Identifiers

PMID23392248
PMCPMC3710367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.